Clinical and economic evaluation of using granulocyte colony-stimulating factor after autologous peripheral blood progenitor cell transplantation in children.
González-Vicent
Marta
M
Department of Pediatrics, Division of Pediatric Hematology-Oncology, Niño Jesús Children's Hospital, Menéndez Palayo 65, 28009 Madrid, Spain.
Madero
Luis
L
Sevilla
Julián
J
Díaz
Miguel Angel
MA
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D019337:Hematologic Neoplasms / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000191:economics*; D017721:Hospital Costs; D006801:Humans; D007223:Infant; D017053:Infection Control / Q000191:economics; D007958:Leukocyte Count; D015993:Life Tables; D008297:Male; D009369:Neoplasms / Q000628:therapy; D009503:Neutropenia / Q000517:prevention & control; D009504:Neutrophils / Q000276:immunology; D017713:Platelet Transfusion / Q000191:economics; D014182:Transplantation, Autologous / Q000191:economics; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D016179:Granulocyte Colony-Stimulating Factor